Table 1.
Patient characteristics of the 301 patients with advanced ovarian epithelial cancer
| Characteristics | n/N | % | |
|---|---|---|---|
| Age |
Mean 56.6 y (range, 21–86 y) |
|
|
| FIGO stage |
|
|
|
| |
III |
277/301 |
92.0% |
| |
IV |
24/301 |
8.0% |
| Histology |
|
|
|
| |
Serous |
148/301 |
49.2% |
| |
Undifferentiated |
116/301 |
38.5% |
| |
Endometrioid |
17/301 |
5.6% |
| |
Mucinous |
15/301 |
5.0% |
| |
Others |
5/301 |
1.7% |
| Tumor grade |
|
|
|
| |
G1 |
27/301 |
9.0% |
| |
G2 |
66/301 |
21.9% |
| |
G3 |
208/301 |
69.1% |
| Ascites > 500 ml |
|
62/301 |
20.6% |
| Primary Cytoreductive Surgery |
|
240/301 |
79.7% |
| Interval Debulking Surgery |
|
61/301 |
20.3% |
| Residual Disease after surgery |
|
|
|
| |
R0 |
209/301 |
69.4% |
| |
R < 0.5 |
35/301 |
11.6% |
| |
R2 |
57/301 |
19% |
| |
R0 in G3 |
130/208 |
62.5% |
| R0 in G1-2 | 79/93 | 84.9% |